NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Ownership - Who owns Lexicon Pharmaceuticals?

Insider buying vs selling

Have Lexicon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kristen AlexanderVP Finance and Accounting2025-02-2817,862$0.67
$11.97kSell
Brian T. CrumSVP General Counsel Secr.2025-02-2845,622$0.67
$30.57kSell
Lisa DefrancescoSVP IR and Corp Comm2025-02-289,096$0.67
$6.09kSell
Craig B. GranowitzSVP Chief Medical Officer2025-02-2865,308$0.67
$43.76kSell
Alan J. MainEVP Innov Chem Sciences2025-02-2843,434$0.67
$29.10kSell
Wendy McDermottSVP Human Resources2025-02-2830,004$0.67
$20.10kSell

1 of 1

LXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXRX insiders and whales buy or sell their stock.

LXRX Shareholders

What type of owners hold Lexicon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
International Sca Artal88.12%318,557,433$183.17MInsider
Raymond Debbane73.53%265,814,646$152.84MInsider
Participations Sa Rl Artal37.67%136,180,481$78.30MInsider
Artal Group Sa37.67%136,180,481$78.30MInstitution
Fmr LLC14.38%51,970,455$29.88MInstitution
Siren LLC10.77%38,918,903$22.38MInstitution
Amaury Wittouck9.79%35,402,689$20.36MInsider
Invus Public Equities LP9.79%35,402,689$20.36MInsider
Siren LLC9.79%35,402,689$20.36MInsider
Cv Invus8.37%30,248,505$17.39MInsider

1 of 3

LXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXRX25.27%74.73%Net SellingNet Selling
THRD66.17%33.83%Net Selling
CRVS55.31%44.07%Net Buying
SLRN73.25%26.75%Net SellingNet Selling
DSGN45.50%54.50%Net Selling

Lexicon Pharmaceuticals Stock Ownership FAQ

Who owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (NASDAQ: LXRX) is owned by 82.34% institutional shareholders, 243.52% Lexicon Pharmaceuticals insiders, and 0.00% retail investors. International Sca Artal is the largest individual Lexicon Pharmaceuticals shareholder, owning 318.56M shares representing 88.12% of the company. International Sca Artal's Lexicon Pharmaceuticals shares are currently valued at $202.92M.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.